Predict First: BMS Executives Discuss Company’s AI Approach
Summary
Bristol Myers Squibb (BMS) executives discuss the company's innovative 'Predict First' strategy, leveraging AI and machine learning to enhance drug discovery and development processes.
Why It Matters
This article highlights BMS's forward-thinking approach to integrating AI in drug development, which could significantly impact the pharmaceutical industry by improving efficiency and patient outcomes. Understanding such strategies is crucial for stakeholders in healthcare and technology sectors.
Key Takeaways
- BMS is implementing AI to streamline drug discovery and development.
- The 'Predict First' strategy aims to enhance the evaluation of drug candidates.
- BMS's AI initiatives date back to before the COVID-19 pandemic, indicating long-term commitment.
- The company has established partnerships to leverage AI for clinical trials and precision treatment.
- BMS compares the current state of AI to the early days of personal computing, suggesting significant transformative potential.
genprowebdirectory Facebook Linkedin RSS Twitter Youtube GEN Edge Featured News Multimedia Content News Insights Topics Artificial Intelligence Bioprocessing Cancer Drug Discovery Genome Editing Infectious Diseases OMICs Translational Medicine Magazine Browse Issues Subscribe Multimedia Summits Webinars GEN Live Learning Labs Podcasts Videos Resources A-Lists eBooks/Perspectives Tutorials Peer-Reviewed Journals GEN Biotechnology Re:Gen Open New Products Subscribe Get GEN Magazine Get GEN eNewsletters Search Facebook Linkedin RSS Twitter Youtube Sign in Welcome! Log into your account your username your password Forgot your password? Get help Privacy Policy Password recovery Recover your password your email A password will be e-mailed to you. GEN – Genetic Engineering and Biotechnology News GEN Edge Featured News Multimedia Content News Insights Topics Artificial Intelligence Bioprocessing Cancer Drug Discovery Genome Editing Infectious Diseases OMICs Translational Medicine Magazine Browse Issues Subscribe Multimedia Summits Webinars GEN Live Learning Labs Podcasts Videos Resources A-Lists eBooks/Perspectives Tutorials Peer-Reviewed Journals GEN Biotechnology Re:Gen Open New Products Subscribe Get GEN Magazine Get GEN eNewsletters Home Topics Artificial Intelligence Predict First: BMS Executives Discuss Company’s AI Approach Bristol Myers Squibb (BMS) says it is applying artificial intelligence (AI) and machine learning, combining those with its researchers’ expertise in dru...
